Fibrobiologics Inc
FBLG0.609USD
-0.040-6.18%
終値 08/04, 16:00（ET）15分遅れの株価
24.86M時価総額
損失額直近12ヶ月PER
詳細情報 Fibrobiologics Inc 企業名
FibroBiologics, Inc. is a cell therapy regenerative medicine company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). The Company is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat Multiple sclerosis (MS) and has completed the Phase I study. The Company is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing.
企業情報
企業コードFBLG
会社名Fibrobiologics Inc
上場日Jan 31, 2024
最高経営責任者「CEO」Mr. Pete O'Heeron
従業員数13
証券種類Ordinary Share
決算期末Jan 31
本社所在地455 E. Medical Center Blvd
都市HOUSTON
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号77598
電話番号12816715150
ウェブサイトhttps://fibrobiologics.com/
企業コードFBLG
上場日Jan 31, 2024
最高経営責任者「CEO」Mr. Pete O'Heeron
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
31.25K
+177.78%
Dr. Victoria Niklas, M.D.
Dr. Victoria Niklas, M.D.
Independent Director
Independent Director
7.50K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Director
Director
7.50K
--
Mr. Nic Johnson
Mr. Nic Johnson
IR Contact Officer
IR Contact Officer
--
--
Mr. Ruben Garcia
Mr. Ruben Garcia
General Counsel
General Counsel
--
--
Mr. Pete O'Heeron
Mr. Pete O'Heeron
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Richard Cilento, Jr.
Mr. Richard Cilento, Jr.
Independent Director
Independent Director
--
--
Ms. Stacy Coen
Ms. Stacy Coen
Independent Director
Independent Director
--
--
Mr. Matthew Link
Mr. Matthew Link
Independent Director
Independent Director
--
--
Mr. Jason D. Davis
Mr. Jason D. Davis
Chief Financial Officer
Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
31.25K
+177.78%
Dr. Victoria Niklas, M.D.
Dr. Victoria Niklas, M.D.
Independent Director
Independent Director
7.50K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Director
Director
7.50K
--
Mr. Nic Johnson
Mr. Nic Johnson
IR Contact Officer
IR Contact Officer
--
--
Mr. Ruben Garcia
Mr. Ruben Garcia
General Counsel
General Counsel
--
--
Mr. Pete O'Heeron
Mr. Pete O'Heeron
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Mon, Jul 28
更新時刻: Mon, Jul 28
株主統計
種類
株主統計
株主統計
比率
O'Heeron (Peter)
14.10%
Golden Knight Inc LP
5.10%
BlackRock Institutional Trust Company, N.A.
3.90%
The Vanguard Group, Inc.
3.39%
Geode Capital Management, L.L.C.
1.47%
Other
72.05%
株主統計
株主統計
比率
O'Heeron (Peter)
14.10%
Golden Knight Inc LP
5.10%
BlackRock Institutional Trust Company, N.A.
3.90%
The Vanguard Group, Inc.
3.39%
Geode Capital Management, L.L.C.
1.47%
Other
72.05%
種類
株主統計
比率
Individual Investor
15.84%
Investment Advisor
11.61%
Corporation
5.58%
Investment Advisor/Hedge Fund
4.21%
Research Firm
0.60%
Hedge Fund
0.18%
Bank and Trust
0.07%
Venture Capital
0.05%
Pension Fund
0.03%
Other
61.83%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
123
14.61M
38.17%
+89.36K
2025Q1
124
14.64M
40.12%
+123.60K
2024Q4
115
14.16M
40.30%
-9.06K
2024Q3
108
15.43M
44.70%
+1.86M
2024Q2
83
13.39M
40.93%
+2.95M
2024Q1
29
10.41M
31.81%
+483.30K
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
O'Heeron (Peter)
5.91M
15.44%
--
--
Apr 21, 2025
Golden Knight Inc LP
2.13M
5.58%
+9.85K
+0.46%
Apr 21, 2025
BlackRock Institutional Trust Company, N.A.
1.63M
4.27%
-25.68K
-1.55%
Mar 31, 2025
The Vanguard Group, Inc.
1.42M
3.71%
+508.69K
+55.79%
Mar 31, 2025
Geode Capital Management, L.L.C.
614.64K
1.61%
+9.71K
+1.61%
Mar 31, 2025
State Street Global Advisors (US)
566.45K
1.48%
-8.07K
-1.40%
Mar 31, 2025
Cascade Financial Partners, LLC
260.08K
0.68%
-22.52K
-7.97%
Mar 31, 2025
Northern Trust Investments, Inc.
201.64K
0.53%
-13.77K
-6.39%
Mar 31, 2025
UBS Financial Services, Inc.
112.86K
0.29%
-15.33K
-11.96%
Mar 31, 2025
Optivise Advisory Services, LLC
110.10K
0.29%
--
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Russell 2000 Growth ETF
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
Texas Capital Texas Small Cap Equity Index ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
0%
iShares Russell 2000 Growth ETF
比率0%
ProShares Hedge Replication ETF
比率0%
Global X Russell 2000 ETF
比率0%
ProShares UltraPro Russell2000
比率0%
Proshares Ultra Russell 2000
比率0%
Texas Capital Texas Small Cap Equity Index ETF
比率0%
iShares Russell 2000 ETF
比率0%
iShares Micro-Cap ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
